Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience

Granulocyte transfusions are a relatively safe adjunctive therapeutic option for patients with chronic granulomatous disease and severe/refractory bacterial or fungal infections. Early initiation, high frequency and sustained therapy is associated with significantly better outcomes.

http://ift.tt/2mWneYf